Format

Send to

Choose Destination
J Infect Dis. 2015 May 1;211(9):1373-5. doi: 10.1093/infdis/jiu648. Epub 2014 Nov 24.

Raising expectations for subunit vaccine.

Author information

1
Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.

Abstract

Multidose regimens are recommended for all prophylactic subunit vaccines. Recent findings from clinical trials of an human papillomavirus virus-like particle vaccine suggest that it may be possible to develop effective single-dose subunit vaccines. The broad implications of these findings are discussed, and the importance of antigen structure and adjuvant in achieving this goal is considered. In conclusion, we argue for the inclusion of single-dose arms in future trials of vaccines, especially if they are based on induction of antibodies by virus-like displayed antigens.

KEYWORDS:

HBV; HPV; antibody; memory B cell; plasma cell; prophylactic vaccine; virus-like particle

Comment in

PMID:
25420478
PMCID:
PMC4400525
DOI:
10.1093/infdis/jiu648
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center